Extracorporeal Membrane Oxygenation in Diffuse Alveolar Hemorrhage Secondary to Systemic Lupus Erythematosus
Abstract
 Diffuse alveolar hemorrhage (DAH) is a rare and potentially deadly  			complication of systemic lupus erythematosus (SLE). We report two  			adult cases where extracorporeal membrane oxygenation (ECMO) was  			used as rescue therapy for severe respiratory failure in this  			setting. We discuss the risk related to coagulation disturbance and  			the need for the circuit anticoagulation in this particular setting.  			We also briefly discuss the clinical problem of lack of knowledge on  			the bioavailability of the immunosuppressive treatment with the use  			of ECMO. We think that ECMO should be used as rescue therapy in  			patients with DAH caused by SLE,  but strategies for  			anticoagulation require further precision.
J Clin Med Res. 2014;6(2):145-148
doi: http://dx.doi.org/10.14740/jocmr1685w
		J Clin Med Res. 2014;6(2):145-148
doi: http://dx.doi.org/10.14740/jocmr1685w
Keywords
Extracorporeal membrane oxygenation; Diffuse alveolar hemorrhage; Systemic lupus erythematosus; Systemic anticoagulation; Continuous veno-venous hemodialysis; Bioavailability
		



 
  
  
  
  
  Email this article
			Email this article